Sana Biotechnology
SANA
SANA
123 hedge funds and large institutions have $804M invested in Sana Biotechnology in 2023 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 38 increasing their positions, 41 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
3% more funds holding
Funds holding: 120 → 123 (+3)
2.16% more ownership
Funds ownership: 68.31% → 70.47% (+2.2%)
7% less repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 41
Holders
123
Holding in Top 10
3
Calls
$8.23M
Puts
$123K
Top Buyers
| 1 | +$44.6M | |
| 2 | +$9.13M | |
| 3 | +$4.47M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$3.65M |
| 5 |
Millennium Management
New York
|
+$1.54M |
Top Sellers
| 1 | -$8.76M | |
| 2 | -$7.18M | |
| 3 | -$6.13M | |
| 4 |
FP
Flagship Pioneering
Cambridge,
Massachusetts
|
-$5.66M |
| 5 |
State Street
Boston,
Massachusetts
|
-$5.1M |